Fundraising Fox

Jayson Rieger

Investor

Managing Partner at PBM Capital · Board director at Verrica Pharmaceuticals

Greater Boston

Find your path to Jayson

819 people in our graph share verified history with Jayson — schools, employers, funds. One of them is your warm intro.

Arsalan TavakoliunlockedJayson: together at University of Virginia (2001–2002)
×3Jayson: together at University of Virginia Darden School of Business
×8Jayson: together at University of Virginia

About

Jayson Rieger is President and CEO of Verrica Pharmaceuticals, with experience spanning drug discovery, R&D operations, and business development. He has led teams through drug discovery and development programs involving in-house resources, CROs/CMOs, and academic and corporate partnerships, and has been the principal executive in M&A, IPO, and capital-raising transactions. He has authored or co-authored more than thirty peer-reviewed publications, is a co-inventor on more than thirty-five issued or pending patents, and has served as principal or co-investigator on over ten NIH grants totaling more than $20 million in research funding.

Board director at Verrica Pharmaceuticals

Intro paths

In turn, Jayson can intro founders to Verrica Pharmaceuticals's investors below.

Verrica Pharmaceuticals's investors · 1

Experience

  1. Verrica PharmaceuticalsCEO and Presidentcurrent2024 — present
  2. PBM Capital GroupExecutive Vice President2014 — 2024
  3. Pavilion XI Partners, LLCPresident2013 — 2014
  4. Intrexon CorporationPresident, Human Therapeutics Division (HTD), Corporate Senior Vice-President2012 — 2013Germantown, MD
  5. Forest LaboratoriesVice President, Research and Virginia Operations2011 — 2012Greater Charlottesville Area
  6. Clinical DataVice President, Research and Virginia Operations2008 — 2011Greater Charlottesville Area
  7. Adenosine Therapeutics, LLCVice President, Lead Development2002 — 2008Greater Charlottesville Area

Skills & more

Negotiation9Team Leadership9Strategic Planning7Management13Strategy16Leadership11Contract Negotiation7Cross-functional Team Leadership25Drug Discovery36Pharmaceuticals2Biotechnology26Entrepreneurship12
+12 moreDrug DevelopmentChemistryProject ManagementTechnology TransferCommercializationLifesciencesClinical TrialsMedicinal ChemistryClinical DevelopmentProduct DevelopmentFDAPharmacology

From Jayson's professional profile.

Deals · 2

Xalud Therapeutics, Inc.Board seat

via PBM Capital · filed Jun 2021 · $30M raise

Verrica PharmaceuticalsBoard seat

via PBM Capital · filed Dec 2015

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at PBM Capital

Frequently asked questions

Who is Jayson Rieger?
Jayson Rieger is President and CEO of Verrica Pharmaceuticals, with experience spanning drug discovery, R&D operations, and business development. He has led teams through drug discovery and development programs involving in-house resources, CROs/CMOs, and academic and corporate partnerships, and has been the principal executive in M&A, IPO, and capital-raising transactions. He has authored or co-authored more than thirty peer-reviewed publications, is a co-inventor on more than thirty-five issued or pending patents, and has served as principal or co-investigator on over ten NIH grants totaling more than $20 million in research funding.
Where does Jayson Rieger work?
Jayson Rieger is Managing Partner at PBM Capital and Board director at Verrica Pharmaceuticals.
What boards does Jayson Rieger sit on?
Jayson Rieger holds tracked board seats at Verrica Pharmaceuticals, Xalud Therapeutics, Inc..
Where did Jayson Rieger go to school?
Jayson Rieger studied at University of Virginia Darden School of Business (MBA, Business Administration and Management); University of Virginia (Ph.D., Medicinal Chemistry); Rollins College (B.A., Chemistry).

Founder mafias

Same school

Shared employers